Cotrimoxazole prophylaxis increases resistance gene prevalence and α-diversity but decreases β-diversity in the gut microbiome of human immunodeficiency virus-exposed, uninfected infants
Clinical infectious diseases
Open Access Publication
Rights and Permissions
Alaric W D’Souza, Eshia Moodley-Govender, Bertram Berla, Tejas Kelkar, Bin Wang, Xiaoqing Sun, Brodie Daniels, Anna Coutsoudis, Indi Trehan, Gautam Dantas, Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants, Clinical Infectious Diseases, Volume 71, Issue 11, 1 December 2020, Pages 2858–2868, https://doi.org/10.1093/cid/ciz1186. © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
D'Souza, Alaric W; Moodley-Govender, Eshia; Berla, Bertram; Kelkar, Tejas; Wang, Bin; Sun, Xiaoqing; Daniels, Brodie; Coutsoudis, Anna; Trehan, Indi; and Dantas, Gautam, "Cotrimoxazole prophylaxis increases resistance gene prevalence and α-diversity but decreases β-diversity in the gut microbiome of human immunodeficiency virus-exposed, uninfected infants." Clinical infectious diseases. 71, 11. 2858 - 2868. (2020).
Supplemental material is available for this article at publisher site.